Skip to content
  • Who We Are
    • CPA President & Vice President
    • CPA Council
    • CPA Team
    • Alliances
    • Member Associations
    • Partners
    • Trustees
    • Patrons
    • Fellows
  • Strategy
    • Our Impact
  • Join
  • Careers
  • Our Work
    • AMR
    • COVID-19
    • CPD
    • PharmAid
    • Tools and Resources
  • Latest
    • Events
    • News
    • Blog
    • Publications
    • Work with Us
  • Support Us
  • Contact
Menu
  • Who We Are
    • CPA President & Vice President
    • CPA Council
    • CPA Team
    • Alliances
    • Member Associations
    • Partners
    • Trustees
    • Patrons
    • Fellows
  • Strategy
    • Our Impact
  • Join
  • Careers
  • Our Work
    • AMR
    • COVID-19
    • CPD
    • PharmAid
    • Tools and Resources
  • Latest
    • Events
    • News
    • Blog
    • Publications
    • Work with Us
  • Support Us
  • Contact
linkedinCreated with Sketch. InstagramCreated with Sketch. FacebookCreated with Sketch. TwitterCreated with Sketch. Youtube

PPS Short Report and Intervention Guide

PPS Short Report and Intervention Guide

A new, free resource from CPA to support point prevalence surveillance

The Commonwealth Pharmacists Association (CPA) is delighted to share our new Point Prevalence Surveillance of Antimicrobial Use: Short Report and Intervention Guide.

The Guide aims to support facilities conducting point prevalence surveillance (PPS), aiding them in interpreting their PPS report and suggesting relevant interventions to improve antimicrobial use. It is compatible with both the Global PPS and World Health Organisation methodologies, and includes:

  • A summary guide of potential PPS findings and the corresponding opportunities for an antimicrobial stewardship (AMS) intervention
  • Guidance on how to make the most of your PPS report, with suggested specific interventions based on the opportunities identified
  • A matrix to assist with categorising AMS interventions to ensure they drive meaningful change

Click here or on the photo of the Guide below to download this FREE resource today.

“With 35 million people predicted to die in the next 25 years as a result of drug-resistant infections, it is imperative that we take action to reduce their spread and safeguard antimicrobials for the future.

“Data is the starting point and key to understanding the problem, but turning that data into improving practice is a challenge.

“We hope that this guide gives a simple and accessible starting point to support any healthcare worker at any level of facility to undertake antimicrobial stewardship to improve how we use antimicrobials and work to safeguard these valuable medicines and reduce AMR.”

Kelly Alexander

Antimicrobial Resistance Technical Lead, SPARC

This Guide is being delivered as part of a pilot initiative in collaboration with several other project teams supported by the Fleming Fund:

  • City St George’s, University of London (Antibiotic Policy Group)
  • Fondation Mérieux
  • Global PPS
  • Management Sciences for Health

and has been supported by CPA teams from our antimicrobial resistance (AMR) programmes:

  • Commonwealth Partnerships for AMS (delivered in partnership with Global Health Partnerships)
  • Surveillance and Prescribing Support for AMS Resource Capacity Building (SPARC)

About CPA's AMR programmes and the Fleming Fund

The Department of Health and Social Care’s Fleming Fund is a UK aid programme supporting up to 25 countries across Africa and Asia to tackle antimicrobial resistance (AMR), a leading public health threat across the world. The Fleming Fund invests in strengthening data surveillance systems through a portfolio of country grants, regional grants and fellowships managed by Mott MacDonald, and global projects managed by partners.

Who we are

  • Alliances
  • Membership
  • Contact Us
  • Our Constitution
  • Alliances
  • Membership
  • Contact Us
  • Our Constitution

About us

  • Strategy
  • News
  • Blog
  • Safeguarding Policy
  • Strategy
  • News
  • Blog
  • Safeguarding Policy

Our work

  • AMR
  • COVID-19
  • CPD
  • PharmAid
  • Tools and Resources
  • AMR
  • COVID-19
  • CPD
  • PharmAid
  • Tools and Resources
© 2026 CPA
  • Privacy Notice
  • Terms & Conditions
  • Disclaimer
  • Cookie Policy (UK)
  • Privacy Statement (UK)
  • Cookie Policy (EU)
  • Privacy Statement (EU)
  • Privacy Notice
  • Terms & Conditions
  • Disclaimer
  • Cookie Policy (UK)
  • Privacy Statement (UK)
  • Cookie Policy (EU)
  • Privacy Statement (EU)

CIO Registered charity number: 1176132

Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behaviour or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}